PACK-CXL: Cross-linking the cornea… to conquer infection
EyeWorld’s Jonathan Kahn (JK) interviews Farhad Hafezi (FH) for a PACK-CXL update.
Mark Hillen
October 18, 2018
EyeWorld’s Jonathan Kahn (JK) interviews Farhad Hafezi (FH) for a PACK-CXL update.
Farhad Hafezi was interviewed by Eyetube on the K-MAP keratoconus prevalence study at ESCRS 2018.
Prof. Hafezi an a video interview with EyeWorld at ESCRS 2018.
The ELZA Institute’s surgeons and researchers spent four days in Vienna at the 36th Congress of the ESCRS, and went to the meeting with a busy schedule!
Why did the Serbian military offer to fly Prof. Farhad Hafezi in a helicopter to a ski resort in early September? After all, the slopes were green with grass, not white with snow.
Presenting to the Swiss Optometrists Association (SBAO) Annual Meeting, Hafezi identified the single biggest villain in the development of keratoconus: eye rubbing.
Other vision healthcare professionals regularly refer patients to ELZA who have “challenging corneas”; many are those whose original laser refractive surgery didn’t quite go to plan, and they need re-treatment to fix their vision
Children: to cross-link or not to cross-link? If a person is going to develop keratoconus, that person is more likely to be a child than an adult.
Keratoconus is the progressive thinning of the cornea, and corneal cross-linking (CXL) can successfully treat it.
Prof. Hafezi in a video interview with EyeWorld at the World Ophthalmology Congress 2018 in Barcelona about the relationship between thyroid hormone and changes in the cornea and in vision.